Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

MabCare Out-Licenses PTK7 ADC to Day One Biopharma in $1.2 Billion Deal

publication date: Jun 20, 2024

Shanghai MabCare Therapeutics out-licensed global rights (ex-China) for its ADC targeting protein-tyrosine kinase 7 (PTK7) candidate to Day One Biopharma, a San Francisco area company, for $55 million upfront and $1.15 billion in milestones. MabCare is also eligible for low-to-mid single-digit royalties. The deal is Day One’s first foray into ADCs. The US FDA approved an IND for MTX-13 (now known as DAY30) earlier this year. MabCare said the candidate showed efficacy against solid tumors in preclinical testing. Day One expects to start US trials at the end of 2024. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here